Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The rostromedial tegmental nucleus gates fat overconsumption through ventral tegmental area output in male rats
    Published on 2024-04-03
    2 years ago
  • Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression
    Published on 2024-03-27
    2 years ago
  • Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia
    Published on 2024-03-27
    2 years ago
  • Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
    Published on 2024-03-24
    2 years ago
  • Kappa-opioid receptor stimulation in the nucleus accumbens shell and ethanol drinking: Differential effects by rostro-caudal location and level of drinking
    Published on 2024-03-24
    2 years ago
  • Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer’s disease
    Published on 2024-03-22
    2 years ago
  • Adolescent nicotine exposure induces long-term, sex-specific disturbances in mood and anxiety-related behavioral, neuronal and molecular phenotypes in the mesocorticolimbic system
    Published on 2024-03-22
    2 years ago
« Previous 1 … 100 101 102 103 104 … 143 Next »
Journal of Psychopharmacology
  • A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression
    Published on 2021-05-03
    5 years ago
  • Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study
    Published on 2021-05-03
    5 years ago
  • Equasy revisited
    Published on 2021-05-03
    5 years ago
  • The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects
    Published on 2021-05-03
    5 years ago
  • Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors
    Published on 2021-04-28
    5 years ago
  • Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
    Published on 2021-04-28
    5 years ago
  • Easier patient access to medical cannabis carries risks as well as benefits
    Published on 2021-04-28
    5 years ago
« Previous 1 … 100 101 102 103 104 … 154 Next »
European Neuropsychopharmacology
  • Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
    Published on 2021-09-10
    5 years ago
  • Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depression
    Published on 2021-09-10
    5 years ago
  • Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials
    Published on 2021-09-04
    5 years ago
  • Well-Being, Resilience and Post-traumatic growth in the Era of Covid-19 Pandemic
    Published on 2021-09-03
    5 years ago
  • Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up
    Published on 2021-09-02
    5 years ago
  • Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder
    Published on 2021-08-28
    5 years ago
  • Drugs do not work if patients do not take them
    Published on 2021-08-14
    5 years ago
« Previous 1 … 100 101 102 103 104 … 170 Next »

   Pharma Pub